AKT1 and type 2 diabetes mellitus: Several studies have indicated that the overactivation of the mTOR pathway can disrupt the IRS1/PI3K/AKT signaling pathway, resulting in hepatic gluconeogenesis and glycogen breakdown, while also inhibiting glucose uptake in muscle and adipose tissue, thereby exacerbating T2DM and IR (Bu et al. 2025).